Earnings call transcript: Envipco's Q2 2025 revenue slides, stock dips

Envipco Holding NV's Q2 2025 revenue declined 13% year-over-year to €23.1 million, prompting a 2.18% pre-market stock drop, despite a gross margin improvement to 36.6%. While investors reacted cautiously to the top-line miss, the company is strategically expanding into new markets like Poland and Portugal with secured orders and launching its high-volume Quantum machine in the U.S., aiming to capitalize on a projected tripling of the reverse vending machine market. Analysts forecast a 31% sales growth for fiscal year 2025 and a return to profitability this year, though the timing of revenue realization from new markets remains a key variable.

Analysis

Envipco Holding NV (ENVI) reported mixed Q2 2025 results, characterized by a near-term revenue contraction against a backdrop of significant long-term growth prospects. Group revenues declined 13% year-over-year to €23.1 million, primarily driven by lower reverse vending machine (RVM) sales in Europe as the company transitions from fulfilling prior orders to capitalizing on new market openings. This top-line miss, coupled with a sharp drop in EBITDA to €400,000 from €2.6 million in the prior-year quarter, triggered a 2.18% pre-market stock decline. However, the company demonstrated improved operational efficiency, with gross margin expanding to 36.6% and the balance sheet remaining robust, evidenced by a current ratio of 2.03 and a newly secured €21 million working capital facility to fund expansion.

The forward-looking outlook remains the core of the investment thesis. Management highlighted a legislatively-driven market opportunity poised to triple in the coming years, equivalent to a €4 billion addressable market. The company has secured foundational orders in new high-potential markets, including 1,000 units in Poland and 250 in Portugal, with revenue fulfillment expected primarily in Q4 2025. This aligns with analyst forecasts for a return to profitability this year and a significant 31% sales growth for fiscal year 2025. The primary risk is timing, as uncertainty in new market regulations, such as in Poland, could delay final customer decisions and revenue recognition, making this a pivotal execution story for the second half of the year.

Key Decisions for Investors

• Investors should weigh the reported 13% Q2 revenue decline and compressed EBITDA against the significant, legislatively-driven growth pipeline in new European markets like Poland and Portugal.
• The timing of revenue conversion from secured orders is a critical variable; monitor execution in Q4 2025, as guided by management, to validate the analyst forecast of 31% sales growth for fiscal year 2025.
• Pay close attention to the Capital Markets Day on September 9 for further details on the company's strategic targets, which could provide crucial clarity on its path to capitalizing on the projected €4 billion market opportunity.
• Note the improving gross margin of 36.6% and strengthened liquidity, which position the company to fund its expansion as new market rollouts accelerate, mitigating some risk associated with the current revenue dip.